BeiGeneius Hematology Summit – From trial data to individual patients in chronic lymphocytic leukemia and Waldenström’s macroglobulinemia
An international faculty shares expert insights on current management approaches and emerging developments in CLL and WM, infection prevention and treatment, applications of AI in hemato-oncology, and best practices in patient communication and mental health.
From trial data to individual patients in CLL

Status talk: Where are we with the use of MRD to guide CLL treatment decisions?

From trial data to individual patients in WM

Audience-driven panel discussion: Hot topics in CLL and WM

Managing infection risk and vaccinations in CLL and WM

Principles of good HCP–patient communication

Panel discussion: Exploring communication and mental health challenges of hematologists and their patients

Looking into the future: Using AI in hemato‑oncology to facilitate personalized and informed interventions
